MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517051760 A) filed by Merck Patent Gmbh, Darmstadt, Germany, on May 29, for 'toll-like receptor 7 agonists as immune-stimulators to elicit the innate antitumor immunity.'
Inventor(s) include Shan, Min; Wakim, Jean; and Goutopoulos, Andreas.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds that can specifically activate TLR7. The compounds of the invention are useful because they can stimulate innate immunity. The compounds of the invention can be used in the treatment of conditions including cancer, v...